BioAuxilium Research expands its cell-signaling assay portfolio

By The Science Advisory Board staff writers

February 10, 2022 -- BioAuxilium Research is expanding its no-wash Thunder time-resolved Förster resonance energy transfer (TR-FRET) technology portfolio by introducing new cell-signaling pathway and biomarker research assay kits, along with a panel of mix-and-match toolbox reagents. The new offering brings the company's portfolio to a total of 104 products.

Developed and manufactured at BioAuxilium's laboratories, the new Thunder TR-FRET assay kits are ideal for studying intra or extracellular signaling pathways and include key human kinases, proinflammatory cytokines, and a cyclic adenosine monophosphate detection kit designed for screening and characterizing G protein-coupled receptors.

The Thunder TR-FRET toolbox reagents include europium and far-red labeled antispecies, antiepitope, and streptavidin for enabling easy in-house assay development. All Thunder TR-FRET products are extensively validated to ensure specificity, sensitivity, and reproducibility using real-life biological samples, according to the company.

BioAuxilium is a private Canadian biotechnology tool company founded by assay scientists.


Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.